Global Preventive Vaccines Market
Published Date:5 Feb 2020
Category:Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Activating Probable Propositions Amidst COVID-19 Crisis
With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More
The vaccine market is not the same as any other product market. The vaccine market has very different characteristics that increase the complexity of price and purchasing assessment and understanding in their context. It consists of individual markets for individual vaccines or vaccine types, each with specific characteristics, in particular on the supply side. Also, the new candidates for vaccination against cancer and HIV who are under development should reach the magical stage. In the past, multinational vaccine companies have done a lot of innovation, research and development in the field of vaccine production. The companies have used their significant sales, global scale and broad expertise to finance these R & D efforts. New technologies will also be introduced to reduce the time and costs involved in the discovery and production of new vaccines. Despite the success of vaccines, infectious diseases are still a major cause of disease worldwide. At least 40 serious infectious diseases are still not controlled by vaccinations.
Compared to the pharmaceutical market it is relatively small, although growing at a fast rate. There are several factors driving the growth of the global preventive vaccines market. Some of these are: Increasing number of products, increasing awareness, increasing investments in R&D, Technological advancements, increasing government funded projects and associations promoting vaccination, growing demand in the developing countries (China and India) of the Asia-Pacific region. There are restrains for this market as well, these include high regulatory intervention and high costs.
The market is segmented on the basis of technology, type, disease indication, route of administration, end user, and region. Based on the end user, the vaccines market is segmented into pediatrics and adults. The adult segment is expected to register the highest CAGR during the forecast period. Factors like the increasing investments by companies for the development of new adult vaccines and government initiatives for immunization are driving the growth of this segment.
Regionally the market can be segmented into 4 major geographies: Europe, Asia Pacific, North America and ROW. North America is expected to dominate the market, followed by Europe. The high growth of the North American market will be due to the increasing investments by government organizations and companies to promote immunization as well as develop new vaccines. Asia is expected to register the highest CAGR during the forecast period. Increasing investments by companies in the emerging countries of the Asian region such as India and China and rising disposable income will be the main reasons behind the growth.
Some of the major players in the market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co., Inc. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur SA (France), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Daiichi Sankyo (Japan) and Panacea Biotec (India).
The report contains comprehensive analysis on:
Preventive Vaccines Market Segments
Preventive Vaccines Market Drivers, Restraints and Opportunities
Preventive Vaccines Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Preventive Vaccines Market Current Trends
Competition &Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Preventive Vaccines Market includes
US and Canada
Mexico, Brazil, Argentina and Rest of Latin America
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Rest of Eastern Europe
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
In-depth Market Segmentation
Historical and Projected Market Sizing in terms of volume and value
Recent market trends and Impact Factors
R&D Status and Technology Overview
Extensive Industry Structure Coverage